Boosted by award-winning ‘BIG’ innovations, Five9 (FIVN) is floating right around a new buy point.
To kick off 2021, the provider of cloud-based contact center solutions was named a winner in the 2021 BIG Innovation Awards in January.
In addition to recognizing the artificial intelligence-driven Five9 Agent Assist offering, the Business Intelligence Group also gave honors to the Inference Studio Platform from Inference Solutions. In late 2020, Five9 acquired Inference Solutions, an Intelligent Virtual Agent (IVA) provider.
Enhanced with AI technology, the Five9 Intelligent Cloud Contact Center provides digital engagement, analytics, workflow automation, and workforce optimization to create more human customer experiences and deliver tangible business results.
As a pioneer in expanding customer experiences via cloud and AI technology, Five9 has announced its annual Customer Experience (CX) Summit to be held in September.
Five9 Joins Fellow CX Leader Concentrix On IBD Breakout Stocks Index
After hitting an all-time high in early March, Five9 retreated sharply. The silver lining of that pullback is that the cloud and AI technology leader reset its base count by undercutting the low in its prior chart pattern, making the current formation a first-stage base. But it’s been a somewhat messy one.
Flashing a bit of roller coaster action within the base, Five9 is now building a handle, offering a 194.77 entry. On Tuesday, the stock just completed the handle, which takes a minimum of five days to form. Fiven9 also managed to close just above its 21-day moving average.
The technical action in the stock chart reflects the mix of pass and fail fundamental ratings in Stock Checkup. Five9 earns a strong 95 Composite Rating and a solid track record of sales growth. The company has posted 30% average annual revenue growth over the last three years, including a 45% jump last quarter.
Earnings growth has been mixed. Five9 has delivered annual average EPS growth of 59% over the last three years. But analysts expect earnings to slow by 33% in its next quarterly report, and an 8% slowdown for the year.
Although Five9 did not make the latest list of new buys by the best mutual funds, 152 funds with an A+ rating have a position in FIVN stock, including T. Rowe Price New Horizons (PRNHX).
IBD Breakout Opportunities ETF
The IBD Breakout Opportunities ETF from Innovator Capital Management tracks the IBD Breakout Stocks Index. As with other index ETFs, this allows you to essentially invest in the entire index in addition to or rather than buying individual stocks. Learn more here about the ETF and Innovator funds.
Follow Matthew Galgani on Twitter at @IBD_MGalgani.
YOU MIGHT ALSO LIKE: